When U.S. Health Secretary Robert F. Kennedy Jr. announced on Aug. 5 that nearly $500 million to research mRNA vaccines would be canceled, it was one in a continuing line of moves that have put his ...
The Department of Health and Human Services (HHS) announced this week it is beginning a "coordinated wind-down" of federally funded mRNA vaccine development. This includes terminating awards and ...
CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...
Zacks Investment Research on MSN
Moderna (MRNA) Beats Stock Market Upswing: What Investors Need to Know
Moderna (MRNA) closed the most recent trading day at $28.38, moving +2.83% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.06%. At the same ...
WASHINGTON (AP) — So-called mRNA vaccines saved millions of lives during the COVID-19 pandemic — and now scientists are using that Nobel Prize-winning technology to try to develop vaccines and ...
Zacks Investment Research on MSN
Moderna (MRNA) Dips More Than Broader Market: What You Should Know
Moderna (MRNA) closed the most recent trading day at $24.61, moving -4.91% from the previous trading session. This change lagged the S&P 500's 0.5% loss on the day. Elsewhere, the Dow lost 0.38%, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback